Clinical Challenges: Thromboembolic Risk in Pediatric Cardiomyopathy
Children with cardiomyopathy are one of the highest-risk pediatric groups for developing thrombosis, along with kids with Fontan circulation, systemic-to-pulmonary artery shunt-dependent functionally univentricular circulation, central lines, and Kawasaki disease with coronary aneurysms. Prophylaxis to prevent thromboembolism and associated complications for children with cardiac disease is most commonly done with antiplatelets (such as aspirin and […]